View Agent
| Agent Info | |
| Agent: | orteronel |
| Synonyms: | TAK-700 |
| Drug Status For Certain Diseases: | Prostate cancer(phase III) |
| Classification: | an investigational, nonsteroidal, oral, inhibitor of androgen synthesis with greater specificity for 17,20-lyase than for 17α-hydroxylase |
| Target: | 17 alpha-hydroxylase-C17 20-lyase |
| KEGG Pathway: | NA |
| Wiki Pathway: | Metapathway biotransformation Prostate Cancer Glucocorticoid & Mineralcorticoid Metabolism Oxidation by Cytochrome P450 Phase 1 - Functionalization of compounds Metabolism of steroid hormones and vitamin D Steroid Biosynthesis |